查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1660669

2025 年至 2033 年肿瘤分子诊断市场报告（按癌症类型、产品、技术、最终用户和地区）

Oncology Molecular Diagnostics Market Report by Cancer Type, Product, Technology, End-User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

2024IMARC Group全球肿瘤分子诊断市场规模达到 48 亿美元。癌症发生率的上升、分子诊断技术的不断进步以及精准医疗的普及是推动市场成长的主要因素。

肿瘤分子诊断透过分析癌细胞的生物分子来识别癌细胞的存在。对血液、唾液和肿瘤组织样本进行几项测试，以检测和测量 DNA、RNA 和细胞蛋白质中的特定基因序列。肿瘤分子诊断有助于快速分析并提供详细信息，进一步用于癌症的个人化治疗。这些诊断解决方案可用于临床和即时诊断（POC）测试以早期发现癌症。它们也用于血库，以识别捐献血液样本中存在的病原体和传染病。

由于生活方式的改变、老年人口的增加以及吸烟趋势的增加而导致的癌症患病率上升是推动全球肿瘤分子诊断市场增长的主要因素之一。除此之外，对快速且准确诊断的需求不断增长，以及下一代定序 (NGS) 技术的进步，也促进了市场的成长。此外，患有病毒和细菌感染的人数增加以及捐血活动的参与度不断提高，对全球肿瘤分子诊断的需求产生了积极影响。然而，由于冠状病毒病（COVID-19）的突然爆发，一些医疗机构正在采取措施减少就诊次数，以减轻疫情对癌症患者的风险。此外，由于诊断资源被重新用于提供 COVID-19 检测，从而导致肿瘤学检测减少，癌症患者的定期筛检也有所下降。

本报告解答的关键问题

  • 全球肿瘤分子诊断市场迄今表现如何？
  • COVID-19 对全球肿瘤分子诊断市场有何影响？
  • 主要的区域市场有哪些？
  • 根据癌症类型，市场分布如何？
  • 根据产品，市场如何划分？
  • 基于科技的市场分化是怎样的？
  • 根据最终用户，市场分布如何？
  • 该产业的价值链分为哪些阶段？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球肿瘤分子诊断市场的结构是怎样的？
  • 产业的竞争程度如何？

目录

第 1 章：前言

第 2 章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球肿瘤分子诊断市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依癌症类型

  • 乳癌
    • 市场趋势
    • 市场预测
  • 摄护腺癌
    • 市场趋势
    • 市场预测
  • 大肠直肠癌
    • 市场趋势
    • 市场预测
  • 子宫颈癌
    • 市场趋势
    • 市场预测
  • 肝癌
    • 市场趋势
    • 市场预测
  • 肺癌
    • 市场趋势
    • 市场预测
  • 血癌
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第七章：市场区隔：依产品

  • 仪器
    • 市场趋势
    • 市场预测
  • 试剂
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依技术

  • 聚合酶炼式反应（PCR）
    • 市场趋势
    • 市场预测
  • 原位杂交
    • 市场趋势
    • 市场预测
  • 晶片和微阵列
    • 市场趋势
    • 市场预测
  • 等温核酸扩增技术（INAAT）
    • 市场趋势
    • 市场预测
  • 质谱分析
    • 市场趋势
    • 市场预测
  • DNA 和 NGS 定序
    • 市场趋势
    • 市场预测
  • 转录介导扩增 (TMA)
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 医院和诊所
    • 市场趋势
    • 市场预测
  • 参考实验室
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场区隔：依国家
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Agilent Technologies, Inc.
    • Abbott Laboratories
    • Bayer AG
    • Becton, Dickinson and Company
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Hologic, Inc.
    • Qiagen NV
    • Siemens Healthcare
    • Sysmex Corporation
Product Code: SR112025A2396

The global oncology molecular diagnostics market size reached USD 4.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 14.3 Billion by 2033, exhibiting a growth rate (CAGR) of 12.37% during 2025-2033. The rising prevalence of cancer, ongoing advancements in molecular diagnostic technologies, and increased adoption of precision medicine are primarily driving the market's growth.

Oncology molecular diagnostics identify the presence of cancer cells by analyzing their biological molecules. Several tests are performed on the blood, saliva, and tumor tissue samples for detecting and measuring specific genetic sequences in the DNA, RNA, and cell proteins. Oncology molecular diagnostics help perform rapid analysis and provide detailed information that is further utilized in the personalized treatment of cancer. These diagnostics solutions find application in clinical and point-of-care (POC) testing for early detection of cancer. They are also used in blood banks to identify pathogens and infectious diseases present in the donated blood samples.

The rising prevalence of cancer on account of changing lifestyles, growing geriatric population, and the increasing trend of smoking represents one of the major factors impelling the global oncology molecular diagnostics market growth. Apart from this, the escalating demand for rapid and accurate diagnosis, along with advancements in next generation sequencing (NGS) techniques, is contributing to the growth of the market. Furthermore, a rise in the number of individuals suffering from viral and bacterial infections and the increasing participation in blood donation campaigns is positively influencing the demand for oncology molecular diagnostics worldwide. However, due to the sudden outbreak of the coronavirus disease (COVID-19), several healthcare institutions are undertaking steps to mitigate the risk of the pandemic on cancer patients by reducing the number of medical appointments. Moreover, regular screening for cancer patients has witnessed a decline due to the repurposing of diagnostics resources for providing COVID-19 testing and consequent reduction in oncology testing.

Key Market Segmentation:

Breakup by Cancer Type:

  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Liver Cancer
  • Lung Cancer
  • Blood Cancer
  • Others

Breakup by Product:

  • Instruments
  • Reagents
  • Others

Breakup by Technology:

  • Polymerase Chain Reaction (PCR)
  • In Situ Hybridization
  • Chips and Microarrays
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Mass Spectrometry
  • DNA and NGS Sequencing
  • Transcription Mediated Amplification (TMA)
  • Others

Breakup by End-User:

  • Hospitals and Clinics
  • Reference Laboratories
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies, Inc., Abbott Laboratories, Bayer AG, Becton, Dickinson and Company, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic, Inc., Qiagen N.V., Siemens Healthcare and Sysmex Corporation.

Key Questions Answered in This Report

  • How has the global oncology molecular diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global oncology molecular diagnostics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the cancer type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global oncology molecular diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oncology Molecular Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Cancer Type

  • 6.1 Breast Cancer
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Prostate Cancer
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Colorectal Cancer
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Cervical Cancer
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Liver Cancer
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Lung Cancer
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Blood Cancer
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Instruments
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Reagents
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Polymerase Chain Reaction (PCR)
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 In Situ Hybridization
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Chips and Microarrays
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Mass Spectrometry
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 DNA and NGS Sequencing
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Transcription Mediated Amplification (TMA)
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast
  • 8.8 Others
    • 8.8.1 Market Trends
    • 8.8.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Reference Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies, Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Abbott Laboratories
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Becton, Dickinson and Company
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Danaher Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 SWOT Analysis
    • 15.3.6 F. Hoffmann-La Roche AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 SWOT Analysis
    • 15.3.7 Hologic, Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Qiagen N.V.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Siemens Healthcare
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sysmex Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Oncology Molecular Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Oncology Molecular Diagnostics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Oncology Molecular Diagnostics Market: Breakup by Cancer Type (in %), 2024
  • Figure 4: Global: Oncology Molecular Diagnostics Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Oncology Molecular Diagnostics Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Oncology Molecular Diagnostics Market: Breakup by End-User (in %), 2024
  • Figure 7: Global: Oncology Molecular Diagnostics Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 9: Global: Oncology Molecular Diagnostics (Breast Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Oncology Molecular Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Oncology Molecular Diagnostics (Prostate Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Oncology Molecular Diagnostics (Prostate Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Oncology Molecular Diagnostics (Colorectal Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Oncology Molecular Diagnostics (Colorectal Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Oncology Molecular Diagnostics (Cervical Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Oncology Molecular Diagnostics (Cervical Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Oncology Molecular Diagnostics (Liver Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Oncology Molecular Diagnostics (Liver Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Oncology Molecular Diagnostics (Lung Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Oncology Molecular Diagnostics (Lung Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Oncology Molecular Diagnostics (Blood Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Oncology Molecular Diagnostics (Blood Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Oncology Molecular Diagnostics (Other Cancer Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Oncology Molecular Diagnostics (Other Cancer Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Oncology Molecular Diagnostics (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Oncology Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Oncology Molecular Diagnostics (Reagents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Oncology Molecular Diagnostics (Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Oncology Molecular Diagnostics (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Oncology Molecular Diagnostics (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Oncology Molecular Diagnostics (Polymerase Chain Reaction-PCR) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Oncology Molecular Diagnostics (Polymerase Chain Reaction-PCR) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Oncology Molecular Diagnostics (In Situ Hybridization) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Oncology Molecular Diagnostics (In Situ Hybridization) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Oncology Molecular Diagnostics (Chips and Microarrays) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Oncology Molecular Diagnostics (Chips and Microarrays) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Oncology Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology-INAAT) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Oncology Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology-INAAT) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Oncology Molecular Diagnostics (Mass Spectrometry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Oncology Molecular Diagnostics (Mass Spectrometry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Global: Oncology Molecular Diagnostics (DNA and NGS Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Global: Oncology Molecular Diagnostics (DNA and NGS Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Global: Oncology Molecular Diagnostics (Transcription Mediated Amplification-TMA) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Global: Oncology Molecular Diagnostics (Transcription Mediated Amplification-TMA) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Global: Oncology Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Global: Oncology Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Global: Oncology Molecular Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Global: Oncology Molecular Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Global: Oncology Molecular Diagnostics (Reference Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Global: Oncology Molecular Diagnostics (Reference Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Global: Oncology Molecular Diagnostics (Other End-Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Global: Oncology Molecular Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: North America: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: North America: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: United States: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: United States: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Canada: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Canada: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Asia Pacific: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Asia Pacific: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: China: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: China: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Japan: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Japan: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: India: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: India: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: South Korea: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: South Korea: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Australia: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Australia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Indonesia: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Indonesia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Europe: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Europe: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Germany: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Germany: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: France: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: France: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: United Kingdom: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: United Kingdom: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Italy: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Italy: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Spain: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Spain: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Russia: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Russia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 90: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 91: Latin America: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 92: Latin America: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 93: Brazil: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 94: Brazil: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 95: Mexico: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 96: Mexico: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 97: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 98: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 99: Middle East and Africa: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 100: Middle East and Africa: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 101: Global: Oncology Molecular Diagnostics Industry: SWOT Analysis
  • Figure 102: Global: Oncology Molecular Diagnostics Industry: Value Chain Analysis
  • Figure 103: Global: Oncology Molecular Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oncology Molecular Diagnostics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Cancer Type (in Million USD), 2025-2033
  • Table 3: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 4: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 5: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 6: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Oncology Molecular Diagnostics Market Structure
  • Table 8: Global: Oncology Molecular Diagnostics Market: Key Players